Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 29 Breast Neoplasms 28 Brain Neoplasms 21 Neoplasms 16 Glioma 10 Pancreatic Neoplasms 9 Head and Neck Neoplasms 8 Lymphoma 7 Uterine Cervical Neoplasms 6 Urinary Bladder Neoplasms 6 Rectal Neoplasms 6 Glioblastoma 6 Colonic Neoplasms 6 Carcinoma, Hepatocellular 6 Lymphoma, Non-Hodgkin 5 Lung Neoplasms 5 Astrocytoma 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Liver Neoplasms 4 Disease 4 Central Nervous System Neoplasms 4 Stomach Neoplasms 3 Spinal Cord Neoplasms 3 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Esophageal Neoplasms 3 Carcinoma in Situ 3 Retinoblastoma 2 Pathologic Complete Response 2

Interventions

Standard of Care 2 pembrolizumab 1 gadobutrol 1 Radiotherapy 1 Radiation 1 Quality of Life 1 Proton Therapy 1 Practice Guidelines as Topic 1 Physical Examination 1 Patient Reported Outcome Measures 1 Multiparametric Magnetic Resonance Imaging 1 Molecular Diagnostic Techniques 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Lymph Node Excision 1 Limonene 1 Immunotherapy 1 Erlotinib Hydrochloride 1 Drug Therapy 1 Docetaxel 1 Citric Acid 1 Cisplatin 1 Biological Therapy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Parotid Neoplasms × Magnetic Resonance Imaging × Clear all

NCT02294838 2016-11-28

SPIT

British Columbia Cancer Agency

Phase NA Unknown

Parotid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡